Metformin Ingen Pharma

Metformin Hydrochloride, the active ingredient in Metformin Ingen Pharma, is a biguanide presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus and works by improving the body’s response to insulin. GNH USA supplies Metformin Ingen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is a biguanide antidiabetic that acts on glucose metabolism to lower blood sugar levels.

- Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c. - Prediabetes (impaired fasting glucose): delays progression to overt diabetes. - Polycystic ovary syndrome (off‑label): helps reduce insulin resistance and may improve menstrual regularity.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes. - Hypoglycaemia: uncommon when used alone. - Vitamin B12 deficiency: may develop with long‑term use. - Pancreatitis: very rare inflammatory condition of the pancreas.

Metformin Hydrochloride requires careful monitoring in several clinical situations.

- Renal function assessment: avoid use in severe renal impairment. - Hepatic function evaluation: monitor liver disease patients closely. - Lactic acidosis risk: discontinue before radiographic contrast procedures. - Elderly dosing: consider lower starting dose due to decreased renal reserve. - Concomitant medication review: assess for drugs that may affect renal clearance. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride can interact with various medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis; withhold metformin before and after exposure. - Cimetidine: may raise metformin plasma concentrations. - MAO inhibitors: potential for hypertensive reactions.

Moderate Interactions (Monitor Closely): - Alcohol: enhances risk of lactic acidosis. - Diuretics: may affect renal function and metformin clearance. - Beta‑blockers: can mask hypoglycaemia symptoms. - Corticosteroids: may raise blood glucose, requiring dose adjustment. - Thyroid hormones: may influence glucose metabolism.